IRIS Accounts Production v23.3.0.418 11547277 Board of Directors 1.9.22 31.8.23 31.8.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh115472772022-08-31115472772023-08-31115472772022-09-012023-08-31115472772021-08-31115472772021-09-012022-08-31115472772022-08-3111547277ns10:Originalns15:EnglandWales2022-09-012023-08-3111547277ns14:PoundSterlingns10:Original2022-09-012023-08-3111547277ns10:Originalns10:Director12022-09-012023-08-3111547277ns10:Original2022-09-012023-08-3111547277ns10:Original2023-08-3111547277ns10:Originalns10:PrivateLimitedCompanyLtd2022-09-012023-08-3111547277ns10:Originalns10:SmallEntities2022-09-012023-08-3111547277ns10:Originalns10:AuditExempt-NoAccountantsReport2022-09-012023-08-3111547277ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-09-012023-08-3111547277ns10:SmallCompaniesRegimeForAccountsns10:Original2022-09-012023-08-3111547277ns10:Originalns10:FullAccounts2022-09-012023-08-3111547277ns10:Originalns10:Director22022-09-012023-08-3111547277ns10:Originalns10:RegisteredOffice2022-09-012023-08-3111547277ns10:Original2022-08-3111547277ns10:Originalns5:CurrentFinancialInstruments2023-08-3111547277ns10:Originalns5:CurrentFinancialInstruments2022-08-3111547277ns10:Originalns5:Non-currentFinancialInstruments2023-08-3111547277ns10:Originalns5:Non-currentFinancialInstruments2022-08-3111547277ns5:ShareCapitalns10:Original2023-08-3111547277ns5:ShareCapitalns10:Original2022-08-3111547277ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-08-3111547277ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-08-3111547277ns10:Original2021-09-012022-08-3111547277ns10:Originalns5:PlantMachinery2022-08-3111547277ns10:Originalns5:PlantMachinery2022-09-012023-08-3111547277ns10:Originalns5:PlantMachinery2023-08-3111547277ns10:Originalns5:PlantMachinery2022-08-3111547277ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-08-3111547277ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-08-31
REGISTERED NUMBER: 11547277 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 August 2023

for

FLY TO CURE HEALTHCARE LTD

FLY TO CURE HEALTHCARE LTD (REGISTERED NUMBER: 11547277)

Contents of the Financial Statements
FOR THE YEAR ENDED 31 AUGUST 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


FLY TO CURE HEALTHCARE LTD

Company Information
FOR THE YEAR ENDED 31 AUGUST 2023







DIRECTORS: Dr Murat Ustun
Ms Serpil Mavi Ustun





REGISTERED OFFICE: Ernest House
293 Green Lanes
Palmers Green
London
N13 4XS





REGISTERED NUMBER: 11547277 (England and Wales)





ACCOUNTANTS: ADPL LLP
Chartered Certified Accountants
& Business Advisers
Ernest House
293 Green Lanes
Palmers Green
London
N13 4XS

FLY TO CURE HEALTHCARE LTD (REGISTERED NUMBER: 11547277)

Balance Sheet
31 AUGUST 2023

31.8.23 31.8.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 746 933

CURRENT ASSETS
Debtors 5 8,208 11,138
Cash at bank - 4,744
8,208 15,882
CREDITORS
Amounts falling due within one year 6 10,852 5,440
NET CURRENT (LIABILITIES)/ASSETS (2,644 ) 10,442
TOTAL ASSETS LESS CURRENT
LIABILITIES

(1,898

)

11,375

CREDITORS
Amounts falling due after more than one
year

7

8,634

11,332
NET (LIABILITIES)/ASSETS (10,532 ) 43

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings (10,534 ) 41
SHAREHOLDERS' FUNDS (10,532 ) 43

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

FLY TO CURE HEALTHCARE LTD (REGISTERED NUMBER: 11547277)

Balance Sheet - continued
31 AUGUST 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 1 November 2023 and were signed on its behalf by:





Dr Murat Ustun - Director


FLY TO CURE HEALTHCARE LTD (REGISTERED NUMBER: 11547277)

Notes to the Financial Statements
FOR THE YEAR ENDED 31 AUGUST 2023


1. STATUTORY INFORMATION

Fly to Cure Healthcare Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

In carrying out this assessment, the directors have considered the impact of the Covid-19 pandemic on the trade and finances of the company and wider group and they have taken steps to protect liquidity.
The directors are therefore satisfied that there is no significant risk to the ability of the company to continue as a going concern for at least 12 months from the date of approval of these financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 1 ) .

FLY TO CURE HEALTHCARE LTD (REGISTERED NUMBER: 11547277)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 AUGUST 2023


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 September 2022
and 31 August 2023 1,458
DEPRECIATION
At 1 September 2022 525
Charge for year 187
At 31 August 2023 712
NET BOOK VALUE
At 31 August 2023 746
At 31 August 2022 933

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.23 31.8.22
£    £   
Other debtors 8,208 11,138

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.23 31.8.22
£    £   
Bank loans and overdrafts 6,612 -
Trade creditors 2,160 2,162
Taxation and social security 80 3,278
Other creditors 2,000 -
10,852 5,440

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.8.23 31.8.22
£    £   
Bank loans 8,634 11,332